Induction of apoptosis by retinoids and retinoic acid receptor γ- selective compounds in mouse thymocytes through a novel apoptosis pathway

Z. Szondy, Uwe Reichert, Jean Michel Bernardon, Serge Michel, R. Tóth, Philippe Ancian, E. Ajzner, L. Fésüs

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Retinoic acids are morphogenic signaling molecules that are derived from vitamin A and involved in a variety of tissue functions. Two groups of their nuclear receptors have been identified: retinoic acid receptors (RARs) and retinoic acid X receptors (RXRs). All-trans retinoic acid is the high affinity ligand for RARs, and 9-cis retinoic acid also binds to RXRs with high affinity. In cells at high concentrations, all-trans retinoic acid can be converted to 9-cis retinoic acid via unknown mechanisms. It was previously shown that retinoic acids prevents activation-induced death of thymocytes. Here, we report that both all-trans and 9-cis retinoic acid induce apoptosis of mouse thymocytes and purified CD4+ CD8+ cells in ex vivo cultures, with 9-cis retinoic acid being 50 times more effective. The induction of apoptosis by retinoic acids is mediated by RARγ because (a) the phenomenon can be reproduced only by RARγ-selective retinoic acid analogs, (b) the cell death induced by either retinoic acids or RARγ analogs can be inhibited by RARγ- specific antagonists, and (c) CD4+CD8+ thymocytes express RARγ. In vivo administration of an RARγ analog resulted in thymus involution with the concomitant activation of the apoptosis-related endonuclease and induction of tissue transglutaminase. The RARγ pathway of apoptosis is RNA and protein synthesis dependent, affects the CD4+CD8+ double positive thymocytes, and can be inhibited by the addition of either Ca2+ chelators or protease inhibitors. Using various RAR- and RXR-specific analogs and antagonists, it was demonstrated that stimulation of RARα inhibits the RARγ-specific death pathway (which explains the lack of apoptosis stimulatory effects of all- trans retinoic acid at physiological concentrations) and that costimulation of the RXR receptors (in the case of 9-cis retinoic acid) can neutralize this inhibitory effect. It is suggested that formation of 9-cis retinoic acid may be a critical element in regulating both the positive selection and the 'default cell death pathway' of thymocytes.

Original languageEnglish
Pages (from-to)972-982
Number of pages11
JournalMolecular Pharmacology
Volume51
Issue number6
Publication statusPublished - Jun 1997

Fingerprint

Retinoic Acid Receptors
Retinoids
Thymocytes
Apoptosis
Tretinoin
Cell Death
Retinoid X Receptors
Endonucleases
Cytoplasmic and Nuclear Receptors
Chelating Agents
Protease Inhibitors
Vitamin A

ASJC Scopus subject areas

  • Pharmacology

Cite this

Induction of apoptosis by retinoids and retinoic acid receptor γ- selective compounds in mouse thymocytes through a novel apoptosis pathway. / Szondy, Z.; Reichert, Uwe; Bernardon, Jean Michel; Michel, Serge; Tóth, R.; Ancian, Philippe; Ajzner, E.; Fésüs, L.

In: Molecular Pharmacology, Vol. 51, No. 6, 06.1997, p. 972-982.

Research output: Contribution to journalArticle

@article{d177b9ef77f44106a3829f448462965d,
title = "Induction of apoptosis by retinoids and retinoic acid receptor γ- selective compounds in mouse thymocytes through a novel apoptosis pathway",
abstract = "Retinoic acids are morphogenic signaling molecules that are derived from vitamin A and involved in a variety of tissue functions. Two groups of their nuclear receptors have been identified: retinoic acid receptors (RARs) and retinoic acid X receptors (RXRs). All-trans retinoic acid is the high affinity ligand for RARs, and 9-cis retinoic acid also binds to RXRs with high affinity. In cells at high concentrations, all-trans retinoic acid can be converted to 9-cis retinoic acid via unknown mechanisms. It was previously shown that retinoic acids prevents activation-induced death of thymocytes. Here, we report that both all-trans and 9-cis retinoic acid induce apoptosis of mouse thymocytes and purified CD4+ CD8+ cells in ex vivo cultures, with 9-cis retinoic acid being 50 times more effective. The induction of apoptosis by retinoic acids is mediated by RARγ because (a) the phenomenon can be reproduced only by RARγ-selective retinoic acid analogs, (b) the cell death induced by either retinoic acids or RARγ analogs can be inhibited by RARγ- specific antagonists, and (c) CD4+CD8+ thymocytes express RARγ. In vivo administration of an RARγ analog resulted in thymus involution with the concomitant activation of the apoptosis-related endonuclease and induction of tissue transglutaminase. The RARγ pathway of apoptosis is RNA and protein synthesis dependent, affects the CD4+CD8+ double positive thymocytes, and can be inhibited by the addition of either Ca2+ chelators or protease inhibitors. Using various RAR- and RXR-specific analogs and antagonists, it was demonstrated that stimulation of RARα inhibits the RARγ-specific death pathway (which explains the lack of apoptosis stimulatory effects of all- trans retinoic acid at physiological concentrations) and that costimulation of the RXR receptors (in the case of 9-cis retinoic acid) can neutralize this inhibitory effect. It is suggested that formation of 9-cis retinoic acid may be a critical element in regulating both the positive selection and the 'default cell death pathway' of thymocytes.",
author = "Z. Szondy and Uwe Reichert and Bernardon, {Jean Michel} and Serge Michel and R. T{\'o}th and Philippe Ancian and E. Ajzner and L. F{\'e}s{\"u}s",
year = "1997",
month = "6",
language = "English",
volume = "51",
pages = "972--982",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "6",

}

TY - JOUR

T1 - Induction of apoptosis by retinoids and retinoic acid receptor γ- selective compounds in mouse thymocytes through a novel apoptosis pathway

AU - Szondy, Z.

AU - Reichert, Uwe

AU - Bernardon, Jean Michel

AU - Michel, Serge

AU - Tóth, R.

AU - Ancian, Philippe

AU - Ajzner, E.

AU - Fésüs, L.

PY - 1997/6

Y1 - 1997/6

N2 - Retinoic acids are morphogenic signaling molecules that are derived from vitamin A and involved in a variety of tissue functions. Two groups of their nuclear receptors have been identified: retinoic acid receptors (RARs) and retinoic acid X receptors (RXRs). All-trans retinoic acid is the high affinity ligand for RARs, and 9-cis retinoic acid also binds to RXRs with high affinity. In cells at high concentrations, all-trans retinoic acid can be converted to 9-cis retinoic acid via unknown mechanisms. It was previously shown that retinoic acids prevents activation-induced death of thymocytes. Here, we report that both all-trans and 9-cis retinoic acid induce apoptosis of mouse thymocytes and purified CD4+ CD8+ cells in ex vivo cultures, with 9-cis retinoic acid being 50 times more effective. The induction of apoptosis by retinoic acids is mediated by RARγ because (a) the phenomenon can be reproduced only by RARγ-selective retinoic acid analogs, (b) the cell death induced by either retinoic acids or RARγ analogs can be inhibited by RARγ- specific antagonists, and (c) CD4+CD8+ thymocytes express RARγ. In vivo administration of an RARγ analog resulted in thymus involution with the concomitant activation of the apoptosis-related endonuclease and induction of tissue transglutaminase. The RARγ pathway of apoptosis is RNA and protein synthesis dependent, affects the CD4+CD8+ double positive thymocytes, and can be inhibited by the addition of either Ca2+ chelators or protease inhibitors. Using various RAR- and RXR-specific analogs and antagonists, it was demonstrated that stimulation of RARα inhibits the RARγ-specific death pathway (which explains the lack of apoptosis stimulatory effects of all- trans retinoic acid at physiological concentrations) and that costimulation of the RXR receptors (in the case of 9-cis retinoic acid) can neutralize this inhibitory effect. It is suggested that formation of 9-cis retinoic acid may be a critical element in regulating both the positive selection and the 'default cell death pathway' of thymocytes.

AB - Retinoic acids are morphogenic signaling molecules that are derived from vitamin A and involved in a variety of tissue functions. Two groups of their nuclear receptors have been identified: retinoic acid receptors (RARs) and retinoic acid X receptors (RXRs). All-trans retinoic acid is the high affinity ligand for RARs, and 9-cis retinoic acid also binds to RXRs with high affinity. In cells at high concentrations, all-trans retinoic acid can be converted to 9-cis retinoic acid via unknown mechanisms. It was previously shown that retinoic acids prevents activation-induced death of thymocytes. Here, we report that both all-trans and 9-cis retinoic acid induce apoptosis of mouse thymocytes and purified CD4+ CD8+ cells in ex vivo cultures, with 9-cis retinoic acid being 50 times more effective. The induction of apoptosis by retinoic acids is mediated by RARγ because (a) the phenomenon can be reproduced only by RARγ-selective retinoic acid analogs, (b) the cell death induced by either retinoic acids or RARγ analogs can be inhibited by RARγ- specific antagonists, and (c) CD4+CD8+ thymocytes express RARγ. In vivo administration of an RARγ analog resulted in thymus involution with the concomitant activation of the apoptosis-related endonuclease and induction of tissue transglutaminase. The RARγ pathway of apoptosis is RNA and protein synthesis dependent, affects the CD4+CD8+ double positive thymocytes, and can be inhibited by the addition of either Ca2+ chelators or protease inhibitors. Using various RAR- and RXR-specific analogs and antagonists, it was demonstrated that stimulation of RARα inhibits the RARγ-specific death pathway (which explains the lack of apoptosis stimulatory effects of all- trans retinoic acid at physiological concentrations) and that costimulation of the RXR receptors (in the case of 9-cis retinoic acid) can neutralize this inhibitory effect. It is suggested that formation of 9-cis retinoic acid may be a critical element in regulating both the positive selection and the 'default cell death pathway' of thymocytes.

UR - http://www.scopus.com/inward/record.url?scp=0030960146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030960146&partnerID=8YFLogxK

M3 - Article

C2 - 9187263

AN - SCOPUS:0030960146

VL - 51

SP - 972

EP - 982

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 6

ER -